{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:37:19Z","timestamp":1791895039743,"version":"4.3.4"},"reference-count":88,"publisher":"Rambam Health Corporation","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rambam Maimonides Med J"],"DOI":"10.5041\/rmmj.10418","type":"journal-article","created":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T08:41:09Z","timestamp":1596357669000},"page":"e0027","source":"Crossref","is-referenced-by-count":78,"title":["COVID-19 Compared to Other Pandemic Diseases"],"prefix":"10.5041","volume":"11","author":[{"given":"Silvio Daniel","family":"Pitlik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2983","published-online":{"date-parts":[[2020,7,31]]},"reference":[{"key":"ref0","unstructured":"1. Genomic epidemiology of novel coronavirus - Global subsampling. Updated June 2020. Available at: https:\/\/nextstrain.org\/ncov\/global (accessed July 2, 2020)."},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 China","volume":"382","author":"Guan","year":"2020","unstructured":"2. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 China. N Engl J Med 2020;382:1708-20.","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","unstructured":"3. Tay MZ, Poh CM, R\u00e9nia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 2020;20:363-74.","journal-title":"Nat Rev Immunol"},{"key":"ref3","unstructured":"4. Moderna website. Moderna's Work on a COVID-19 Vaccine Candidate. 2020, Moderna, Inc. Available at: https:\/\/www.modernatx.com\/modernas-work-potential-vaccine-against-covid-19 (accessed July 2, 2020)."},{"key":"ref4","unstructured":"5. Inovio Urgently Focused On Developing Covid-19 Vaccine: Because the World Can't Wait. Inovio Website. 2020, Inovio Pharmaceuticals. Available at: https:\/\/www.inovio.com\/our-focus-serving-patients\/covid-19\/ (accessed July 2, 2020)."},{"key":"ref5","unstructured":"6. Gordon DE, Jang JM, Bouhaddou M, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 2020; April 30. Online ahead of print."},{"key":"ref6","unstructured":"7. Johns Hopkins University & Medicine website. Coronavirus Resource Center. Available at: https:\/\/coronavirus.jhu.edu\/ (accessed July 2, 2020)."},{"key":"ref7","unstructured":"8. European Centre for Disease Prevention and Control. COVID-19 pandemic. Available at: https:\/\/www.ecdc.europa.eu\/en\/covid-19-pandemic (accessed July 2, 2020)."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.cell.2020.04.011","article-title":"The architecture of SARS-CoV-2 transcriptome","volume":"181","author":"Kim","year":"2020","unstructured":"9. Kim D, Lee JY, Yang JS, Kim JW, Kim VN, Chang H. The architecture of SARS-CoV-2 transcriptome. Cell 2020;181:914-21.","journal-title":"Cell"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2174\/1568026620999200517043137","article-title":"Novel drugs targeting the SARS-CoV-2\/COVID 19 machinery","volume":"20","author":"Sternberg","year":"2020","unstructured":"10. Sternberg A, McKee DL, Naujokat C. Novel drugs targeting the SARS-CoV-2\/COVID 19 machinery. Curr Top Med Chem 2020;20:1423-33.","journal-title":"Curr Top Med Chem"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","article-title":"COVID-19 infection: origin, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","unstructured":"11. Shereen MA, Kahn S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res 2020; 24:91-8.","journal-title":"J Adv Res"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Hussain M, Jabeen N, Raza F, et al. Structural variations in human ACE 2 may influence its binding with SARS-CoV-2 spike protein. J Med Virol 2020; April 6. Online ahead of print.","DOI":"10.1002\/jmv.25832"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor binding domain (RBD) of 2019 novel coronavirus: implications for development of RBD protein as a viral attachment inhibitor and vaccine","volume":"17","author":"Tai","year":"2020","unstructured":"13. Tai W, He L, Zhang X, et al. Characterization of the receptor binding domain (RBD) of 2019 novel coronavirus: implications for development of RBD protein as a viral attachment inhibitor and vaccine. Cell Mol Immunol 2020;17:613-20.","journal-title":"Cell Mol Immunol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"104833","DOI":"10.1016\/j.phrs.2020.104833","article-title":"Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor","volume":"157","author":"Li","year":"2020","unstructured":"14. Li Y, Zhov W, Yang L, You R. Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor. Pharmacol Res 2020;157:104833.","journal-title":"Pharmacol Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019 -nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","unstructured":"15. Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based drug repurposing for novel coronavirus 2019 -nCoV\/SARS-CoV-2. Cell Discov 2020;6: 14.","journal-title":"Cell Discov"},{"key":"ref15","unstructured":"16. Combs S. She discovered coronaviruses decades ago- but got little recognition. National Geographic 2020; April 17. Available at: https:\/\/www.national-geographic.com\/history\/2020\/04\/june-almeida-discovered-coronaviruses-decades-ago-little-recognition\/ (accessed July 8, 2020)."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1099\/0022-1317-36-3-495","article-title":"Studies on the structure of a coronavirus-avian infectious bronchitis virus","volume":"36","author":"RW","year":"1977","unstructured":"17. Bingham RW, Almeida JD. Studies on the structure of a coronavirus-avian infectious bronchitis virus. J Gen Virol 1977;36:495-502.","journal-title":"J Gen Virol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v11010041","article-title":"Bats and coronaviruses","volume":"11","author":"Banerjee","year":"2019","unstructured":"18. Banerjee A, Kulcsar K, Misra V, Frieman M, Mossman K. Bats and coronaviruses. Viruses 2019;11:1-15.","journal-title":"Viruses"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.7150\/ijbs.45472","article-title":"Zoonotic origins of human coronaviruses","volume":"16","author":"ZW","year":"2020","unstructured":"19. Ye ZW, Yuan S, Yuen KS, Fung SY, Chan CP, Jin DY. Zoonotic origins of human coronaviruses. Int J Biol Sci 2020;16:1686-97.","journal-title":"Int J Biol Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/jmv.25813","article-title":"Epidemiological analysis of COVID-19 and practical experience from China","volume":"92","author":"Ye","year":"2020","unstructured":"20. Ye Q, Wang B, Mao J, et al. Epidemiological analysis of COVID-19 and practical experience from China. J Med Virol 2020;92:755-69.","journal-title":"J Med Virol"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Zhang T, Wu Q, Zhang Z. Probably pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak. Curr Biol 2020;30:1346-51.e2.","DOI":"10.1016\/j.cub.2020.03.022"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.immuni.2020.04.003","article-title":"COVID-19: a new virus, but a familiar receptor and cytokine release syndrome","volume":"52","author":"Hirano","year":"2020","unstructured":"22. Hirano T, Murakami M. COVID-19: a new virus, but a familiar receptor and cytokine release syndrome. Immunity 2020;52:731-3.","journal-title":"Immunity"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1164\/rccm.202004-1076ED","article-title":"Basing respiratory management of COVID-19 on physiological principles","volume":"201","author":"Tobin","year":"2020","unstructured":"23. Tobin MJ. Basing respiratory management of COVID-19 on physiological principles. Am J Respir Crit Care Med 2020;201:1319-20.","journal-title":"Am J Respir Crit Care Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.dsx.2020.03.013","article-title":"Cardiovascular disease and COVID-19","volume":"14","author":"Bansal","year":"2020","unstructured":"24. Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr 2020;14:247-50.","journal-title":"Diabetes Metab Syndr"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/liv.14470","article-title":"COVID-19 and liver disease","volume":"40","author":"Sun","year":"2020","unstructured":"25. Sun J, Aghemo A, Forner A, Valenti L. COVID-19 and liver disease. Liver Int 2020;40:1278-81.","journal-title":"Liver Int"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/ijd.14956","article-title":"Re: Chilblain-like lesions on feet and hands during COVID-19 epidemic","volume":"59","author":"El-Azhary","year":"2020","unstructured":"26. El-Azhary R. Re: Chilblain-like lesions on feet and hands during COVID-19 epidemic. Inter J Dermatol 2020;59:748.","journal-title":"Inter J Dermatol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation","volume":"135","author":"JM","year":"2020","unstructured":"27. Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood 2020;135: 2033-40.","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jocn.2020.05.017","article-title":"Neurological manifestations and complications of COVID-19: a literature review","volume":"77","author":"Ahmad","year":"2020","unstructured":"28. Ahmad I, Rathore FA. Neurological manifestations and complications of COVID-19: a literature review. J Clin Neurosci 2020;77:8-12.","journal-title":"J Clin Neurosci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","article-title":"Kidney disease is associated with in-hospital death of patients with COVID-19","volume":"97","author":"Cheng","year":"2020","unstructured":"29. Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 2020;97:829-38.","journal-title":"Kidney Int"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(20)31129-6","article-title":"Kawasaki-like disease: emerging complication during the COVID-19 pandemic","volume":"395","author":"RM","year":"2020","unstructured":"30. Viner RM, Whittaker E. Kawasaki-like disease: emerging complication during the COVID-19 pandemic. Lancet 2020;395:1741-3.","journal-title":"Lancet"},{"key":"ref30","unstructured":"31. World Health Organization (WHO). What is a Pandemic? 2010; February 24. Available at: https:\/\/www.who.int\/csr\/disease\/swineflu\/frequently_asked_questions\/pandemic\/en\/ (accessed July 2, 2020)."},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. McMillen CW. Pandemics: A Very Short Introduction. Oxford, UK: Oxford University Press; 2016. ISBN-13: 978-0199340071.","DOI":"10.1093\/actrade\/9780199340071.001.0001"},{"key":"ref32","unstructured":"33. University Press. Pandemics: A Brief History. University Press; 2020. ISBN-13: 979-8635046531"},{"key":"ref33","unstructured":"34. Oldstone MBA. Viruses, Plagues & History: Past, Present and Future. New York, NY; Oxford University Press; 2010. ISBN-13: 978-0195327311"},{"key":"ref34","unstructured":"35. Levine AJ. Viruses: A Scientific American Library Book. New York, NY; Scientific American Library; 1991. ISBN-13: 978-0716750314"},{"key":"ref35","unstructured":"36. Zimmer C. A Planet of Viruses. 2nd ed. Chicago, IL: The University of Chicago Press; 2015. ISBN-13: 978-0226294209"},{"key":"ref36","unstructured":"37. Holmes EC. The Evolution and Emergence of RNA Viruses. Oxford Series in Ecology and Evolution. Oxford, UK: Oxford University Press; 2009. ISBN-13: 978-0199211135"},{"key":"ref37","unstructured":"38. Prestone T. Pandemic: A Brief History of Influenza, The Plague, Cholera, and Other Infectious Diseases That Have Changed the World; How They Started, How They Ended, and The Lessons Learned by Humanity. Prestone Theodore; 2020. ASIN: B087WH75BT"},{"key":"ref38","unstructured":"39. Jarus O. 20 of the worst epidemics and pandemics in history. Live Science website. Available at: https:\/\/www.livescience.com\/worst-epidemics-and-pandemics-in-history.html (accessed July 2, 2020)."},{"key":"ref39","unstructured":"40. MPHonline. Outbreak: 10 of the worst pandemics in history. Available at: https:\/\/www.mphonline.org\/worst-pandemics-in-history\/ (accessed July 2, 2020)."},{"key":"ref40","unstructured":"41. Roos D. How 5 of history's worst pandemics finally ended. History website. Available at: https:\/\/www.history.com\/news\/pandemics-end-plague-cholera-black-death-smallpox (accessed July 2, 2020)."},{"key":"ref41","unstructured":"42. LePan N. Visualizing the history of pandemics. Visual Capitalist website. March 14, 2020. Available at: https:\/\/www.visualcapitalist.com\/history-of-pandemics-deadliest\/ (accessed July 2, 2020)."},{"key":"ref42","unstructured":"43. Centers for Disease Control and Prevention. Influenza (flu): past pandemics. Available at: https:\/\/www.cdc.gov\/flu\/pandemic-resources\/basics\/past-pandemics.html (accessed July 2, 2020)."},{"key":"ref43","unstructured":"44. Robinson D, Battenfield A. The worst outbreaks in U.S. history. Healthline website. Available at: https:\/\/www.healthline.com\/health\/worst-disease-outbreaks-history (accessed July 2, 2020)."},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"45. Greene WC. A history of AIDS: looking back to see ahead. Eur J Immunol 2007;37(Suppl 1):S94-102.","DOI":"10.1002\/eji.200737441"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/clinids\/9.6.1102","article-title":"AIDS in the pre-AIDS era","volume":"9","author":"Huminer","year":"1987","unstructured":"46. Huminer D, Rosenfeld JB, Pitlik SD. AIDS in the pre-AIDS era. Rev Infect Dis 1987;9:1102-8.","journal-title":"Rev Infect Dis"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1098\/rstb.2010.0031","article-title":"The evolution of HIV-1 and the origin of AIDS","volume":"365","author":"PM","year":"2010","unstructured":"47. Sharp PM, Hahn BH. The evolution of HIV-1 and the origin of AIDS. Philos Trans R Soc Lond B Biol Sci 2010;365:2487-94.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/S0140-6736(17)30559-7","article-title":"Cholera","volume":"390","author":"Clemens","year":"2017","unstructured":"48. Clemens JD, Nair JB, Ahmed T, Qadri F, Holmgren J. Cholera. Lancet 2017;390:1539-49.","journal-title":"Lancet"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jinf.2012.09.010","article-title":"Plague: history and contemporary analysis","volume":"66","author":"Raoult","year":"2013","unstructured":"49. Raoult D, Mouffok N, Bitam I, Piarroux R, Drancourt M. Plague: history and contemporary analysis. J Infect 2013;66:18-26.","journal-title":"J Infect"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1080\/22221751.2020.1756700","article-title":"Attenuated SARS-CoV-2 variants with deletions at the S1\/S2 junction","volume":"9","author":"Lau","year":"2020","unstructured":"50. Lau SY, Wang P, Mok BWY, et al. Attenuated SARS-CoV-2 variants with deletions at the S1\/S2 junction. Emerg Microbes Infect 2020;9:837-42.","journal-title":"Emerg Microbes Infect"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1056\/NEJMra1901594","article-title":"Ebola","volume":"382","author":"Feldmann","year":"2020","unstructured":"51. Feldmann H, Sprecher A, Geisbert TW. Ebola. N Engl J Med 2020;382:1832-42.","journal-title":"N Engl J Med"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"52. Taubenberger JK, Kash JC, Morens DM. The 1918 influenza pandemic: 100 years of questions answered and unanswered. Sci Transl Med 2019;11:eaau5485.","DOI":"10.1126\/scitranslmed.aau5485"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/MCC.0000000000000638","article-title":"Severe influenza: overview in critically ill patients","volume":"25","author":"Sarda","year":"2019","unstructured":"53. Sarda C, Palma P, Rello J. Severe influenza: overview in critically ill patients. Curr Opin Crit Care 2019;25: 449-57.","journal-title":"Curr Opin Crit Care"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"54. Drancourt M, Raoult D, eds. Paleomicrobiology of Humans. 1st ed. Washington DC: ASM Press; 2016. ISBN-13: 978-1555819163","DOI":"10.1128\/9781555819170"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"55. Angelakis E, Bechah Y, Raoult D. The history of epidemic typhus. Microbiol Spectr 2016;4.","DOI":"10.1128\/microbiolspec.PoH-0010-2015"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"56. Raoult D. A personal view of how paleomicrobiology aids our understanding of the role of lice in plague epidemics. Microbiol Spectr 2016;4.","DOI":"10.1128\/microbiolspec.PoH-0001-2014"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"57. Drali R, Mumcuoglu K, Raoult D. Human lice in paleoentomology and paleomicrobiology. Microb Spectr 2016;4.","DOI":"10.1128\/microbiolspec.PoH-0005-2014"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-genom-083115-022413","article-title":"Advancements in next-generation sequencing","volume":"17","author":"SE","year":"2016","unstructured":"58. Levy SE, Myers RM. Advancements in next-generation sequencing. Annu Rev Genomics Hum Genet 2016; 17:95-115.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60, 706 humans","volume":"536","author":"Lek","year":"2016","unstructured":"59. Lek M, Karczewski KJ, Minikel EV, et al. Analysis of protein-coding genetic variation in 60, 706 humans. Nature 2016;536:285-91.","journal-title":"Nature"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"60. G\u00f6ker H, Krakulak EA, Demiro\u011flu HD, et al. The effects of blood group types on the risk of COVID-19 infection and its clinical outcome. Turk J Med Sci 2020; June 4. Online ahead of print.","DOI":"10.3906\/sag-2005-395"},{"key":"ref60","unstructured":"61. Rambaut A. Phylogenetic analysis of nCoV-2019 genomes. 2020; March 2. Virological website. Available at: https:\/\/virological.org\/t\/phylodynamic-analysis-176-genomes-6-mar-2020\/356 (accessed July 8, 2020)."},{"key":"ref61","unstructured":"62. Baker M, Fink S. COVID-19 arrived in Seattle. Where it went from there stunned the scientists. The New York Times 2020; April 22. Available at: https:\/\/www.nytimes.com\/2020\/04\/22\/us\/coronavirus-sequencing.html (accessed July 2, 2020)."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","unstructured":"63. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270-3.","journal-title":"Nature"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","unstructured":"64. Lu R, Zhao X, Li J, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565-74.","journal-title":"Lancet"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Andersen","year":"2020","unstructured":"65. Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med 2020;26:450-2.","journal-title":"Nat Med"},{"key":"ref65","unstructured":"66. Gao Z, Xu Y, Sun C, et al. A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect 2020; May 15. Online ahead of print."},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"67. Yelin I, Aharoni N, Tamar ES, et al. Evaluation of COVID-19 RT-q PCR test in multi-sample pools. Clin Infect Dis 2020; May 2:ciaa531. Online ahead of print.","DOI":"10.1093\/cid\/ciaa531"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jebm.12376","article-title":"Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019-nCoV","volume":"13","author":"Zhou","year":"2020","unstructured":"68. Zhou T, Liu Q, Yang Z, et al. Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019-nCoV. J Evid Based Med 2020; 13:3-7.","journal-title":"J Evid Based Med"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"69. Long C, Xu H, Shen Q, et al. Diagnosis of the coronavirus disease (COVID-19): rRT-PCR or CT? Eur J Radiol 2020;126:108961.","DOI":"10.1016\/j.ejrad.2020.108961"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"376","DOI":"10.20344\/amp.13928","article-title":"Excess mortality estimation during the COVID-19 pandemic: preliminary data from Portugal","volume":"33","author":"Nogueira","year":"2020","unstructured":"70. Nogueira PJ, Nobre MA, Nicola PJ, Furtado C, Carneiro AV. Excess mortality estimation during the COVID-19 pandemic: preliminary data from Portugal. Acta Med Port 2020;33:376-83.","journal-title":"Acta Med Port"},{"key":"ref70","unstructured":"71. Rashid ZZ, Othman SN, Samat MNA, Ali UK, Wong KK. Diagnostic performance of COVID-19 serology assays. Malays J Pathol 2020;42:13-21."},{"key":"ref71","unstructured":"72. Snow J. Cholera and the water supply in the South districts of London. J Public Health Sanit Rev 1856; 2:239-57."},{"key":"ref72","unstructured":"73. Vachon D. Part One: Doctor John Snow Blames Water Pollution for Cholera Epidemic. UCLA Department of Epidemiology, Fielding School of Public Health. 2005. Available at: https:\/\/www.ph.ucla.edu\/epi\/snow\/fatherofepidemiology.html (accessed July 2, 2020)."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"513","DOI":"10.4269\/ajtmh.2000.62.513","article-title":"New insights on the emergence of cholera in Latin America during 1991: the Peruvian experience","volume":"62","author":"Seas","year":"2000","unstructured":"74. Seas C, Miranda J, Gil AI, et al. New insights on the emergence of cholera in Latin America during 1991: the Peruvian experience. Am J Trop Med Hyg 2000;62:513-17.","journal-title":"Am J Trop Med Hyg"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.dsx.2020.05.026","article-title":"Impact of complete lockdown on total infection and death rates: a hierarchical cluster analysis","volume":"14","author":"Ghosal","year":"2020","unstructured":"75. Ghosal S, Bhattacharyya R, Majumder M. Impact of complete lockdown on total infection and death rates: a hierarchical cluster analysis. Diabetes Metab Syndr 2020;14:707-11.","journal-title":"Diabetes Metab Syndr"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"76. Morgan AJ, Poland GA. The Jenner Society and the Edward Jenner Museum: tributes to a physician-scientist. Vaccine 2011;29(Suppl 4):D152-4.","DOI":"10.1016\/j.vaccine.2011.08.128"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"77. Kennedy RB, Ovsyannikova I, Poland GA. Smallpox vaccines for biodefense. Vaccine 2009;27:D73-9.","DOI":"10.1016\/j.vaccine.2009.07.103"},{"key":"ref77","unstructured":"78. World Health Organization (WHO). Draft landscape of COVID-19 candidate vaccines. June 29, 2020. Available at: https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines (accessed July 2, 2020)."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/d41586-020-01221-y","article-title":"The race for coronavirus vaccines: a graphical guide","volume":"580","author":"Callaway","year":"2020","unstructured":"79. Callaway E. The race for coronavirus vaccines: a graphical guide. Nature 2020;580:576-7.","journal-title":"Nature"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","article-title":"The COVID-19 vaccine development landscape","volume":"19","author":"TT","year":"2020","unstructured":"80. Le TT, Andreadakis Z, Kumar A, et al. The COVID-19 vaccine development landscape. Nature Rev Drug Discov 2020;19:305-6.","journal-title":"Nature Rev Drug Discov"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40475-020-00201-6","article-title":"The SARS-CoV-2 vaccine pipeline: an overview","volume":"7","author":"Chen","year":"2020","unstructured":"81. Chen WH, Strych U, Hotez PJ, Bottazzi ME. The SARS-CoV-2 vaccine pipeline: an overview. Current Trop Med Rep 2020;7:61-4.","journal-title":"Current Trop Med Rep"},{"key":"ref81","unstructured":"82. Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of COVID-19 - preliminary report. N Engl J Med 2020; May 22. Online ahead of print."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1172\/JCI138745","article-title":"Deployment of convalescent plasma for the prevention and treatment of COVID-19","volume":"130","author":"Bloch","year":"2020","unstructured":"83. Bloch EM, Shoham S, Casadevall A, et al. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest 2020;130:2757-65.","journal-title":"J Clin Invest"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"84. Gans J. Economics in the Age of COVID-19. Cambridge, MA; The MIT Press; 2020. ISBN: 978-0-262-36279-5","DOI":"10.21428\/a11c83b7.c48fa91b"},{"key":"ref84","unstructured":"85. Capital Economics. The economic impact of COVID-19. July 2, 2020. Available at: https:\/\/www.capitaleconomics.com\/the-economic-effects-of-the-coronavirus\/ (accessed July 2, 2020)."},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"86. Ing AJ, Cocks C, Green JP. COVID-19: in the footsteps of Ernest Shackleton. Thorax 2020; May 27. Online ahead of print.","DOI":"10.1136\/thoraxjnl-2020-215091"},{"key":"ref86","unstructured":"87. Corum J, Wu KJ, Zimmer C. Coronavirus drug and treatment tracker. The New York Times 2020; updated July 20. Available at: https:\/\/www.nytimes.com\/interactive\/2020\/science\/coronavirus-drugs-treatments.html (accessed July 21, 2020)."},{"key":"ref87","unstructured":"88. Corum J, Grady D, Wee S-L, Zimmer C. Coronavirus vaccine tracker. The New York Times 2020; updated July 21. Available at: https:\/\/www.nytimes.com\/interactive\/2020\/science\/coronavirus-vaccine-tracker.html"}],"container-title":["Rambam Maimonides Medical Journal"],"original-title":[],"link":[{"URL":"https:\/\/www.rmmj.org.il\/userimages\/1109\/1\/PublishFiles\/1116Article.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T16:02:15Z","timestamp":1738684935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.rmmj.org.il\/issues\/46\/articles\/1116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,31]]},"references-count":88,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,7,31]]}},"URL":"https:\/\/doi.org\/10.5041\/rmmj.10418","relation":{},"ISSN":["2076-9172"],"issn-type":[{"value":"2076-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,31]]}}}